Gold Momentum Lifts ASX 200 as Biotech and Energy Small Caps Surge

5 min read | September 23, 2025 04:57 AM BST | By Sam

Highlights

  • Gold miners push momentum across the market

  • Biotech firms expand through innovation and licensing deals

  • Energy explorers advance projects with international potential

Gold momentum boosts ASX as biotech, energy, and mining small caps shine. Companies like Bio-Gene Technology (ASX:BGT) and Maronan Metals (ASX:MMA) showcase sector growth and market resilience.

The ASX 200 (ASX 200) opened with renewed strength, led by the surge in ASX mining stocks (ASX mining stocks) as gold prices reached record highs. Among the rising sectors, resource companies drove the momentum, while a fresh wave of developments from biotechs and energy players added notable activity. Entities such as Bio-Gene Technology (ASX:BGT), Algorae Pharma (ASX:1AI), and Maronan Metals (ASX:MMA) are commanding investor interest through scientific breakthroughs, partnerships, and project expansions, reflecting the diverse opportunities in the ASX stock market (ASX stock market).

What is Driving Gold Strength?

Precious metals are once again at the centre of the market’s advance. With gold achieving new records, resource-linked players are capturing attention. Podium Minerals (ASX:POD) and ADX Energy (ASX:ADX), while distinct in focus, stand among small caps benefiting indirectly from heightened sentiment in commodities. Rising interest in the sector underlines the importance of ASX ordinaries stocks (ASX ordinaries stocks), as investors broaden exposure beyond large caps.

Which Biotech Firms Are Advancing?

Bio-Gene Technology

Bio-Gene Technology (ASX:BGT) is recognised for its proprietary Flavocide tick control treatment. Laboratory research has highlighted strong efficacy against tick species associated with Lyme disease transmission in the United States. With ongoing development pathways, the company’s formulation is positioned as a unique player in agricultural and health-linked biotech solutions.

Algorae Pharma

Algorae Pharma (ASX:1AI) continues expanding through its AI-driven discovery platform. The business has secured a commercial licensing agreement that will launch oncology therapies in Australia and New Zealand. Beyond this, the company’s research portfolio includes a wide range of oncology targets, reflecting innovation at the intersection of artificial intelligence and drug development.

Which Energy Firms Are in Focus?

Otto Energy

Otto Energy (ASX:OEL) is an oil and gas exploration company with assets across key petroleum basins. Its presence in the small-cap energy space highlights the ongoing role of explorers in diversifying energy supply and creating development options.

ADX Energy

ADX Energy (ASX:ADX) operates as an oil and gas explorer with focus areas in Europe and Africa. The business is actively advancing new resource opportunities that align with broader global energy demand.

What Role Are Small Cap Acquisitions Playing?

Way2Vat

Way2Vat (ASX:W2V), a platform specialising in VAT reclaim and compliance, has secured an agreement to acquire an international VAT advisory firm. The acquisition broadens its client base and strengthens its competitive position in the digital finance compliance industry. This expansion reflects the significance of consolidation strategies among smaller technology-driven firms on the ASX.

How Are Mining Juniors Expanding?

Maronan Metals

Maronan Metals (ASX:MMA) is progressing its underground project with studies indicating the potential for significant silver production. Development options under consideration include either standalone processing facilities or toll treatment partnerships. The findings provide the company with optionality for long-term growth in the resource sector.

Podium Minerals

Podium Minerals (ASX:POD) focuses on platinum group metals exploration and development. Its projects are positioned in prospective mineral regions of Western Australia. Growing interest in clean energy metals has strengthened the visibility of companies like Podium within the ASX 100 (ASX 100) ecosystem.

Which Technology Firms Are Emerging?

Dotz Nano

Dotz Nano (ASX:DTZ) operates in advanced nanotechnology solutions, with applications spanning anti-counterfeiting, tracing, and security. Its innovations target industries requiring traceability and secure verification.

Jayride Group

Jayride Group (ASX:JAY) runs a global travel technology marketplace, enabling pre-booked airport transfers through its online platform. The model integrates transportation providers with travellers seeking seamless connections, reflecting ongoing digital transformation in the travel sector.

What About Smaller Metals and Resources?

Mantle Minerals

Mantle Minerals (ASX:MTL) is engaged in iron ore and base metals exploration. Although facing near-term challenges, its resource assets place it within an important commodity space that remains essential for industrial applications.

Bryah Resources

Bryah Resources (ASX:BYH) focuses on gold, copper, and manganese exploration. Its tenements in Western Australia highlight the region’s potential for resource diversification.

Alma Metals

Alma Metals (ASX:ALM) is an explorer in copper and gold, maintaining interests in highly prospective mineral areas. Its ongoing activities aim to expand resource definition and project potential.

How Are ASX Small Caps Positioned Overall?

The ASX dividend stocks (ASX dividend stocks) theme often draws focus to large caps, but the activity of smaller entities underscores how diverse opportunities shape overall sentiment. While some small caps encounter operational hurdles, others achieve momentum through scientific validation, resource project expansions, or strategic acquisitions. The ASX ordinaries stocks universe therefore continues to serve as a launchpad for innovation-driven growth.

The Australian market, led by gold momentum, has extended its breadth through dynamic moves in biotech, energy, and technology small caps. With Bio-Gene Technology (ASX:BGT) advancing agricultural biotech, Algorae Pharma (ASX:1AI) progressing oncology partnerships, and Maronan Metals (ASX:MMA) delivering on silver development studies, opportunities remain vibrant across diverse industries. These developments demonstrate the unique ecosystem of the ASX stock market, where established players and emerging innovators together shape the market narrative.

Frequently Asked Questions

  • Which companies are making progress in oncology therapies?

    Algorae Pharma (ASX:1AI) has expanded into oncology through a commercial licensing agreement.

  • What makes Bio-Gene Technology’s research significant?

    Bio-Gene Technology (ASX:BGT) has demonstrated strong efficacy for its Flavocide tick control treatment in laboratory trials.

  • Which small cap mining company is focused on silver?

    Maronan Metals (ASX:MMA) is advancing its underground silver project with long-term development options.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next